Preliminary Congress Program


 

Join us for ASER-Perioperative Medicine 2025! This three-day congress features an interactive multidisciplinary program, delving into the latest advancements in Enhanced Recovery and Perioperative Medicine. Explore key principles and practical strategies to improve patient outcomes in your hospital.

Key Highlights:

  • Multidisciplinary Sessions: Gain insights from a diverse range of healthcare professionals.
  • Interactive Discussions: Engage with experts and peers to accelerate learning.
  • Poster Session: Discover cutting-edge research and innovations.
  • Networking Opportunities: Connect with colleagues and expand your professional network.

Note that any aspect of this program is subject to change and this version of the program should not be considered final including presentation timings and poster numbers.


  Thu - Nov 06      Fri - Nov 07      Sat - Nov 08   

FRIDAY, NOVEMBER 7

8:00 - 8:45 AM
CORPORATE SYMPOSIUM
CORPORATE BREAKFAST SYMPOSIUM (NON-CME)- KEEPING THE BALANCE: HEMODYNAMICS AND ERAS IN HARMONY
Helix Hall

Enhanced recovery depends on more than protocols-- it requires precision in practice. This session examines the future of perioperative hemodynamic management, emphasizing the role of goal-directed hemodynamic therapy (GDHT) in advancing ERAS pathways. We'll review the science of blood pressure and flow, insufficient vs. excess fluid and discuss real-world application of how individualized management can improve outcomes.

Speakers:
Mike Grocott, BSc MSc MBBS MD FRCA FRCP FFICM GChPOM (ANZCA)
Professor of Anaesthesia and Critical Care Medicine, University of Southampton, UK

Desirée Chappell, CRNA, FAANA
Vice President Clinical Quality, NorthStar Anesthesia
Co-Editor in Chief and Lead Anchor, TopMedTalk

All faculty are paid consultants of BD (Becton, Dickinson and Company).

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse events.
BD-163219 v1. 0 US


8:55 - 10:25 AM
WORKSHOP
ADVANCES IN PERIOPERATIVE AND WEARABLE MONITORING WORKSHOP (NON-CME)
Chair/Organizer: Anosuhka Afonso, Attila Kett, Ashish Khana, Garry Brydges
Levy

Sponsored By: BD, Caretaker Medical, Medtronic and Ward 24/7
A unique highly interactive, hands-on experience to witness innovative monitoring technologies in action!


10:30 - 11:00 AM
SYMPOSIUM
DECODING THE FLOW: HEMODYNAMICS AND MONITORING IN THE PERIOPERATIVE PERIOD
Chair/Organizer: Ashish Khanna
Hermann Hall


THE EVOLUTION OF ERAS FLUID MANAGEMENT: WHY "RESTRICTION" ISN'T THE GOAL
Desiree Chapell. NorthStar Anesthesia, Irving, TX, USA


PRESSURE POINTS: MASTERING PERIOPERATIVE HEMODYNAMIC CHALLENGES
Tim Miller. Duke University Medical Center, Durham, NC, USA


WEARABLE MONITORING - WHERE DO WE GO NOW?
Ashish Khanna. Wake Forest University School of Medicine, Winston-Salem, NC, USA

11:00 - 11:30 AM
BREAK
COFFEE BREAK/EXHIBITS
Helix Hall

11:30 - 12:50 PM
SYMPOSIUM
NEW FRONTIERS IN PERIOPERATIVE MEDICINE
Chair/Organizer: Garry Brydges
Hermann Hall


11:30

SPECIAL LECTURE: PREDICTIVE POWER: HOW AI IS REDEFINING PERIOPERATIVE MEDICINE
Nassib Chamoun. Health Data Analytics Institute, Dedham, MA, USA


11:50

AI IN ACTION
David Jaffray. The University of Texas MD Anderson Cancer Center, Houston, TX, USA


12:05

AI FOR REAL-TIME PREDICTION OF ADVERSE EVENTS IN INTRAOPERATIVE ANESTHESIA
Jeffrey H. Siewerdsen. The University of Texas MD Anderson Cancer Center, Houston, TX, USA


12:20

PREHABILITATION 2. 0
Mike Grocott. University of Southampton , United Kingdom


12:35

Q&A PANEL.

1:00 - 1:45 PM
CORPORATE SYMPOSIUM
CORPORATE LUNCH SYMPOSIUM (NON-CME) - EXPLORING SODIUM CHANNEL INHIBITION FOR THE MANAGEMENT OF ACUTE PAIN
Helix Hall

Speakers:
Jai Mehta, MD, MBA, FASA
Senior Medical Director
Vertex Pharmaceuticals Incorporated
Boston, MA

Ian Weber, MD
Orthopaedic Surgeon
Centura Health
The Joint Replacement Center at St. Anthony North Hospital
Westminster, CO

Please join us in this session to learn more about the role of suzetrigine, a non-opioid pain signal inhibitor, in the management of moderate-to-severe acute pain. In this session we will explore the role of NaV1. 8 in pain signaling, suzetrigine’s mechanism of action, and findings from our clinical studies evaluating suzetrigine. We will then gain clinical insights on the incorporation of its use in practice through discussions on real-world experience with suzetrigine.


2:00 - 3:30 PM
SYMPOSIUM
REDEFINING PAIN MANAGEMENT WITH INNOVATIVE STRATEGIES
Chair/Organizer: Anoushka Afonso
Hermann Hall


2:00

INNOVATIVE PAIN MEDICATIONS
TJ Gan. The University of Texas MD Anderson Cancer Center, Houston, TX, USA


2:15

BEYOND THE BLOCK: ADVANCES IN REGIONAL ANESTHESIA & PAIN MANAGEMENT
Nadia Hernandez. UTHealth Houston, Houston, TX, USA


2:30

HARNESSING TECHNOLOGY TO OPTIMIZE PAIN MANAGEMENT
Grant Chen. UTHealth Houston, Houston, TX, USA


2:45

Q&A PANEL.

3:30 - 4:00 PM
BREAK
COFFEE BREAK/EXHIBITS
Helix Hall

4:00 - 4:20 PM
SYMPOSIUM
BUSINESS MEETING
Helix Hall

4:20 - 5:00 PM
SYMPOSIUM
THE PROFESSOR HENRIK KEHLET AMERICAN SOCIETY OF ENHANCED RECOVERY AND PERIOPERATIVE MEDICINE LIFETIME ACHIEVEMENT AWARD AND LECTURE (NON-CME)
Helix Hall


IMAGINING THE FUTURE OF PERIOPERATIVE CARE
Mike Grocott. University of Southampton , United Kingdom